AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.10.21	AstraZeneca: Imfinzi Plus Chemotherapy Significantly Improves Survival In 1st-line Advanced BTC (RTTNews)
18.10.21	AstraZeneca Recommends Shareholders Reject TRC Capital's Mini-Tender Offer - Quick Facts (RTTNews)
15.10.21	AZN : Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer (RTTNews)
11.10.21	AstraZeneca : Phase III Trial Shows AZD7442 Reduces Risk Of Developing Severe COVID-19 Or Death (RTTNews)
08.10.21	AstraZeneca: FDA Grants Orphan Drug Designation To Tezepelumab For Eosinophilic Esophagitis (RTTNews)
05.10.21	AstraZeneca Seeks Emergency Nod In US For AZD7442 To Prevent Symptomatic COVID-19 (RTTNews)
04.10.21	AstraZeneca's Enhertu Receives Fourth U.S. Breakthrough Therapy Designation (RTTNews)
24.09.21	AstraZeneca: Lynparza PROpel Phase III Trial In 1st-line MCRPC Meets Primary Endpoint (RTTNews)
23.09.21	RedHill Biopharma Announces Movantik Patent Litigation Settlement With Aurobindo (RTTNews)
20.09.21	AstraZeneca: Enhertu Triples Progression-free Survival In Phase III DESTINY-Breast03 Trial (RTTNews)
18.09.21	AZN : Imfinzi Plus Chemotherapy Triples Patient Survival At 3-yrs In ES-Small Cell Lung Cancer (RTTNews)
18.09.21	AstraZeneca : Enhertu Shows Robust And Durable Tumor Response Of 54.9% In Patients With Lung Cancer (RTTNews)
17.09.21	AZN : Imfinzi Plus Novel Immunotherapies Improve Clinical Outcomes For Patients With Lung Cancer (RTTNews)
09.09.21	AstraZeneca Reports Positive Results From Late-stage Trial For Lung Cancer Treatment (RTTNews)
09.09.21	AstraZeneca: MANDALA, DENALI Phase III Trials Of PT027 For Asthma Meet All Primary Goals (RTTNews)
08.09.21	Hutchmed Says First Patient Dosed In China Phase III Trial Of Orpathys And Tagrisso In Lung Cancer (RTTNews)
05.09.21	Amgen's Tezepelumab Reduces Exacerbations In Patients With Severe Asthma & Comorbid Nasal Polyps (RTTNews)
03.09.21	EU, AstraZeneca Agree On Delivery Of Remaining 200 Mln COVID-19 Vaccine Doses (RTTNews)
03.09.21	AstraZeneca: European Commission Approves Expanded Use Of Ultomiris For Children, Adolescents (RTTNews)
31.08.21	AstraZeneca's FLUMIST QUADRIVALENT Available For Flu Vaccination - Quick Facts (RTTNews)
26.08.21	AstraZeneca's Forxiga Approved In Japan For Chronic Kidney Disease - Quick Facts (RTTNews)
26.08.21	AstraZeneca : Phase III Trial In Wilson Disease Meets Primary Endpoint (RTTNews)
20.08.21	AstraZeneca: Alexion To Discontinue CHAMPION-ALS Phase 3 Trial Of Ultomiris In ALS (RTTNews)
20.08.21	AstraZeneca : Phase III Trial On AZD7442 Meets Primary Endpoint In Preventing COVID-19 (RTTNews)
09.08.21	EU Approves AstraZeneca's Forxiga To Treat Chronic Kidney Disease (RTTNews)
09.08.21	AstraZeneca : Enhertu Improves PFS In Phase 3 Trial On Metastatic Breast Cancer (RTTNews)
02.08.21	FDA Approves AstraZeneca's Saphnelo To Treat Systemic Lupus Erythematosus (RTTNews)
29.07.21	AstraZeneca Q2 Profit Down, Revenues Climb; Updates FY21 Outlook - Quick Facts (RTTNews)
27.07.21	Regeneron In R&D Deal With AstraZeneca For Treatment Of Obesity (RTTNews)
23.07.21	AstraZeneca's T2D Drug BYDUREON BCise Gets Approval In US To Treat Pediatric Patients (RTTNews)
19.07.21	Aridis Acquires Rights For Development And Commercialization Of Suvratoxumab (RTTNews)
19.07.21	Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZeneca (PR Newswire)
19.07.21	China Approves AstraZeneca's Imfinzi To Treat Extensive-stage Small Cell Lung Cancer (RTTNews)
16.07.21	AstraZeneca : FDA Panel Votes Against Approval Of Roxadustat For Anemia (RTTNews)
16.07.21	Moderna To Replace Alexion Pharma In S&P 500 (RTTNews)
16.07.21	Moderna Set to Join S&P 500 (PR Newswire)
14.07.21	U.K. Approves AstraZeneca - Alexion Deal - Quick Facts (RTTNews)
13.07.21	J&J, AstraZeneca Exploring Fixes To Rare Blood Clots Linked To Their Vaccines: WSJ (RTTNews)
08.07.21	Amgen : FDA Grants Priority Review For Tezepelumab In Treatment Of Asthma (RTTNews)
06.07.21	AstraZeneca's Proposed Acquisition Of Alexion Gets EU Clearance - Quick Facts (RTTNews)
28.06.21	AstraZeneca's Forxiga Recommended For Approval In EU For Chronic Kidney Disease Treatment (RTTNews)
28.06.21	AstraZeneca : Trial On Nirsevimab Shows Safety & Tolerability Profile In Infants At High Risk Of RSV (RTTNews)
24.06.21	AZN : China Oks Lynparza To Treat BRCA-mutated Metastatic Castration-resistant Prostate Cancer (RTTNews)
23.06.21	AstraZeneca : China Approves Orpathys For Treatment Of Lung Cancer And MET Gene Alterations (RTTNews)
22.06.21	AstraZeneca : EU Oks Koselugo For Children With Neurofibromatosis Type 1 & Plexiform Neurofibromas (RTTNews)
15.06.21	AstraZeneca : Trial On AZD7442 Fails To Meet Main Goal In Post-exposure Prevention Of COVID-19 (RTTNews)
13.06.21	Italy Suspends AstraZeneca COVID-19 Vaccine For People Under 60 Yrs, After Teenager Dies (RTTNews)
08.06.21	PathAI to Present Machine Learning-based Quality Control Tool for HER2 Testing in Breast Cancer at the American Society of Clinical Oncology Virtual Scientific Program 2021 (PR Newswire)
04.06.21	AstraZeneca Appoints Alexion's Aradhana Sarin To Succeed Marc Dunoyer As New CFO (RTTNews)
04.06.21	AstraZeneca : Late-stage Trial Shows Lynparza Reduces Recurrence, Death In Breast Cancer Patients (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	249.90	3.39 %	K V
Sika	202.20	2.22 %	K V
Givaudan	3’853.00	2.07 %	K V
Kuehne+Nagel Int	190.95	1.84 %	K V
Geberit	553.20	1.36 %	K V
Zurich Insur Gr	568.00	0.35 %	K V
ABB	42.30	0.31 %	K V
Nestle	87.52	0.14 %	K V
Swiss Re	144.90	-0.14 %	K V
Alcon	77.34	-0.77 %	K V

mehr

14.04.25		NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude
04.04.25		Verluste in New York: NASDAQ 100 letztendlich tiefrot
04.04.25		Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse
04.04.25		Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch
04.04.25		Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone
03.04.25		Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100
03.04.25		Schwache Performance in New York: NASDAQ 100 implodiert am Nachmittag
03.04.25		Zurückhaltung in New York: NASDAQ 100 tiefrot

14.04.25

NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude

04.04.25

Verluste in New York: NASDAQ 100 letztendlich tiefrot

04.04.25

Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse

04.04.25

Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch

04.04.25

Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone

03.04.25

Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100